01—Abstract
Summary
Summary of the 8-K filed October 1, 2026. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. (OHI) filed this Current Report on Form 8-K dated October 1, 2026, to disclose a leadership transition under Item 5.02.
Effective October 1, 2026, the Board of Directors appointed Matthew P. Gourmand, the Company's President, as President and Chief Executive Officer, succeeding C. Taylor Pickett, who is retiring as CEO.
The filing states that Mr. Pickett's retirement is not the result of any disagreement with the Company on its operations, policies or practices. The Board also appointed Mr. Gourmand as a director, filling the vacancy left by Mr. Pickett's retirement from the Board for the remainder of Mr. Pickett's term expiring in 2027. The number of directors on the Board remains at eight.
The Board does not currently expect to appoint Mr. Gourmand to any committees. Mr. Gourmand, age 51, has been President since January 1, 2025, and previously served as Senior Vice President of Corporate Strategy & Investor Relations from January 2021 and as Senior Vice President of Investor Relations from October 2017.
Before joining the Company, he worked as an equity portfolio manager, an equity research analyst, and in the audit department of Deloitte. The filing states he will receive no separate director compensation beyond what is provided under his employment agreement, and it discloses no related party transactions or family relationships requiring disclosure.
02—Key points
Key Highlights
- Matthew P. Gourmand, the Company's President, became President and Chief Executive Officer effective October 1, 2026, succeeding C. Taylor Pickett upon Mr. Pickett's retirement.
- Mr. Gourmand was also appointed to the Board of Directors effective October 1, 2026, filling the vacancy left by Mr. Pickett's retirement for the remainder of a term expiring in 2027.
- The filing states Mr. Pickett's retirement is not the result of any disagreement with the Company on its operations, policies or practices.
- The Board remains at eight directors following the appointment, and no committee appointments for Mr. Gourmand are expected at this time.
- Mr. Gourmand has served as President since January 1, 2025, and previously held Senior Vice President roles in Corporate Strategy & Investor Relations and Investor Relations.
- Mr. Gourmand will receive no separate compensation for board service beyond his employment agreement, and the filing discloses no related party transactions.
- The 8-K is signed by Gail D. Makode, Chief Legal Officer and General Counsel, and is dated October 1, 2026.
03—Questions
Frequently Asked Questions
Who is the new Chief Executive Officer of Omega Healthcare Investors?
Matthew P. Gourmand, previously the Company's President, became President and Chief Executive Officer effective October 1, 2026, succeeding C. Taylor Pickett upon Mr. Pickett's retirement.
Is Mr. Pickett's retirement related to any disagreement with the Company?
No. The filing states that Mr. Pickett's retirement is not the result of any disagreement with the Company on any matter related to its operations, policies or practices.
Will Mr. Gourmand join the Board of Directors?
Yes. Effective October 1, 2026, the Board appointed Mr. Gourmand as a director to fill the vacancy created by Mr. Pickett's retirement, for the remaining term of Mr. Pickett's directorship expiring in 2027. The Board remains at eight directors.
What is Mr. Gourmand's background?
Mr. Gourmand, age 51, has been the Company's President since January 1, 2025. He previously served as Senior Vice President of Corporate Strategy & Investor Relations from January 2021 and as Senior Vice President of Investor Relations from October 2017. Earlier, he worked as an equity portfolio manager at Millennium Partners and Stevens Capital Management, an equity research analyst at UBS, and in the audit department of Deloitte. He holds the Chartered Financial Analyst designation.
Will Mr. Gourmand receive additional pay for serving as a director?
No. The filing states Mr. Gourmand will not receive any separate compensation for his director service beyond the compensation provided under his employment agreement with the Company.
04—Continue